ULTRACEMCO and HINDZINC. Monthly data through 2026-10-09. Change the comparison →
Share price change since Jan '19, the first month all 2 have a price: ULTRACEMCO +210%, HINDZINC +109%.
Rebased at 2019-01. Monthly closes from each company's history.
Months with a missing value are left as gaps.
The share price return over 3 years, split into net profit growth, share count change and the change in P/E.
ULTRACEMCO: share price rose 29% over 3 years: +48 pts from net profit growth, −17 pts from the P/E change, −2 pts from share count change.
HINDZINC: share price rose 84% over 3 years: +66 pts from net profit growth, +18 pts from the P/E change.
Segments are percentage points of the price return: price = P/E × net profit ÷ share count. These are the same numbers each company's own page shows.
Each cell is the company's percentile rank among its own sector peers that month. Darker is higher-ranked. Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value.
| Metric | ULTRACEMCO | HINDZINC |
|---|---|---|
| Share Price | ₹10675.00 | ₹543.50 |
| Market Cap | ₹3.15L cr | ₹2.30L cr |
| P/E | 41.5x | 13.6x |
| P/B | 4.2x | 10.2x |
| P/S | 3.7x | 4.9x |
| ROCE | 13.0% | 69.0% |
| ROE | 10.1% | 75.3% |
| Operating margin | 19.0% | 58.0% |
| Revenue (TTM), indexed to 100 | ₹86069 cr | ₹46622 cr |
| Net Profit (TTM) | ₹7571 cr | ₹16933 cr |
| Debt / Equity | 0.3x | 0.4x |
| Cash Conversion Cycle | 13d | 4d |
| Promoter holding | 59.3% | 60.7% |
| FII Holding | 12.4% | 2.2% |
| DII Holding | 19.7% | 5.0% |
| 12M momentum | -8.8% | 14.1% |
| Drawdown from Peak | -14.2% | -20.9% |
| Cash conversion (3Y) | 1.7x | 1.4x |
| Interest cover | 7.2x | 30.3x |
| Share Count Change (1Y) | 0.0% | 0.0% |
| Volatility (1Y) | 23.6% | 40.3% |
Latest month in the data: 2026-10. Highlight marks the higher value, or the lower value for P/E, P/B, P/S, debt, working-capital days, share count change and volatility. It marks a number, not a better investment.
Comparison is descriptive and historical. Highlights mark the higher or lower value on a metric, not a better investment. Not investment advice; ApnaFunda is not a SEBI-registered research analyst.